ob318

Small moleculeexperimental

Clinical trial activity

1 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2017 (NCT02347228)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ob318

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02347228Phase 1Jul 1, 2017Government of Taiwan, Microbio Co Ltd
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Government of TaiwanGovernment1012017
Microbio Co LtdFor profit1112017
2 organizations
Page 1 / 1